• China Nuokang Bio-Pharmaceutical Inc., of Beijing, received a proposal from its chairman and CEO, Baizhong Xue, to take the company private by acquiring all outstanding shares for $5.80 per American Depositary Share. Each Nuokang ADS represents eight Nuokang ordinary shares.